BridgeMD
New treatment option for Asthma
Official title Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma
ClinicalTrials.gov ID: NCT06116292
What this study is testing
- What it's testing
- Introduction: Asthma is one of the most common chronic respiratory diseases worldwide. Despite the extensive knowledge of the condition and available therapeutic options, severe asthmatic patients have poor disease control in 50% of cases.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years with a diagnosis of asthma based on GEMA 5.2 2022.
- Patients seen in the pulmonology service of the center.
- Patients who have not previously received asthma education.
- Capable of giving signed informed consent.
You likely can't join if
- Patient who does not have a mobile device with Android or IOS system.
- Lack of minimum technological knowledge for the use of the application (ESTOI).
- People who are participating or have participated in a clinical trial in the last 6 months.
- Patients diagnosed with other respiratory diseases except for obstructive sleep apnea (OSA), Asthma-COPD overlap syndrome (ACOS).
- Patients with palliative or severe chronic illnesses that limit their life expectancy.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.